
Monoclonal Antibodies Market
Monoclonal Antibodies Market - Global Industry Assessment & Forecast
Segments Covered
By Source Murine, Chimeric, Humanized, Human
By Indication Cancer, Autoimmune Diseases, Inflammatory Diseases, Infectious Diseases, Others
By End User Hospitals, Research Institutes, Others
By Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Snapshot
![]() |
2022 |
![]() |
2023 - 2030 |
![]() |
2017 - 2021 |
![]() |
USD 111.93 Billion |
![]() |
USD 186.67 Billion |
![]() |
6.60% |
![]() |
Asia Pacific |
![]() |
North America |
Customization Offered
Cross-segment Market Size and Analysis for Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market Dynamics
Region Level Market Share
Import Export Analysis
Production Analysis
Others Request Customization Speak To Analyst
-
Executive Dashboard
- Strategic Imperatives
-
Premium Insights
- Top 3 Trends to Watch
- Demand and Supply Trends
- Top 3 Strategies Followed by Major Players
- Top 3 Predictions by Vantage Market Research
- Top Investment Pockets
- Insights from Primary Respondents
-
Global Monoclonal Antibodies Market - Segment Analysis
- Overview
- Global Monoclonal Antibodies Market, 2016 - 2028 (USD Million)
-
Global Monoclonal Antibodies Market - by Source
- By Murine
- By Chimeric
- By Humanized
- By Human
-
Global Monoclonal Antibodies Market - by Indication
- By Cancer
- By Autoimmune Diseases
- By Inflammatory Diseases
- By Infectious Diseases
- By Others
-
Global Monoclonal Antibodies Market - by End User
- By Hospitals
- By Research Institutes
- By Others
-
Global Monoclonal Antibodies Market - by region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
- Market comparative analysis
-
North America Monoclonal Antibodies Market - Segment Analysis
- Overview
- North America Monoclonal Antibodies Market, 2016 - 2028 (USD Million)
-
North America Monoclonal Antibodies Market, by Source
- By Murine
- By Chimeric
- By Humanized
- By Human
-
North America Monoclonal Antibodies Market, by Indication
- By Cancer
- By Autoimmune Diseases
- By Inflammatory Diseases
- By Infectious Diseases
- By Others
-
North America Monoclonal Antibodies Market, by End User
- By Hospitals
- By Research Institutes
- By Others
-
North America Monoclonal Antibodies Market, by Country
- U.S.
- U.S. Monoclonal Antibodies Market, By Source
- By Murine
- By Chimeric
- By Humanized
- By Human
- U.S. Monoclonal Antibodies Market, By Indication
- By Cancer
- By Autoimmune Diseases
- By Inflammatory Diseases
- By Infectious Diseases
- By Others
- U.S. Monoclonal Antibodies Market, By End User
- By Hospitals
- By Research Institutes
- By Others
- U.S. Monoclonal Antibodies Market, By Source
- Canada
- Canada Monoclonal Antibodies Market, By Source
- By Murine
- By Chimeric
- By Humanized
- By Human
- Canada Monoclonal Antibodies Market, By Indication
- By Cancer
- By Autoimmune Diseases
- By Inflammatory Diseases
- By Infectious Diseases
- By Others
- Canada Monoclonal Antibodies Market, By End User
- By Hospitals
- By Research Institutes
- By Others
- Canada Monoclonal Antibodies Market, By Source
- Mexico
- Mexico Monoclonal Antibodies Market, By Source
- By Murine
- By Chimeric
- By Humanized
- By Human
- Mexico Monoclonal Antibodies Market, By Indication
- By Cancer
- By Autoimmune Diseases
- By Inflammatory Diseases
- By Infectious Diseases
- By Others
- Mexico Monoclonal Antibodies Market, By End User
- By Hospitals
- By Research Institutes
- By Others
- Mexico Monoclonal Antibodies Market, By Source
- U.S.
-
Europe Monoclonal Antibodies Market - Segment Analysis
- Overview
- Europe Monoclonal Antibodies Market, 2016 - 2028 (USD Million)
-
Europe Monoclonal Antibodies Market, by Source
- By Murine
- By Chimeric
- By Humanized
- By Human
-
Europe Monoclonal Antibodies Market, by Indication
- By Cancer
- By Autoimmune Diseases
- By Inflammatory Diseases
- By Infectious Diseases
- By Others
-
Europe Monoclonal Antibodies Market, by End User
- By Hospitals
- By Research Institutes
- By Others
-
Europe Monoclonal Antibodies Market, by Country
- Germany
- Germany Monoclonal Antibodies Market, By Source
- By Murine
- By Chimeric
- By Humanized
- By Human
- Germany Monoclonal Antibodies Market, By Indication
- By Cancer
- By Autoimmune Diseases
- By Inflammatory Diseases
- By Infectious Diseases
- By Others
- Germany Monoclonal Antibodies Market, By End User
- By Hospitals
- By Research Institutes
- By Others
- Germany Monoclonal Antibodies Market, By Source
- UK
- UK Market, By Source
- By Murine
- By Chimeric
- By Humanized
- By Human
- UK Market, By Indication
- By Cancer
- By Autoimmune Diseases
- By Inflammatory Diseases
- By Infectious Diseases
- By Others
- UK Market, By End User
- By Hospitals
- By Research Institutes
- By Others
- UK Market, By Source
- France
- France Monoclonal Antibodies Market, By Source
- By Murine
- By Chimeric
- By Humanized
- By Human
- France Monoclonal Antibodies Market, By Indication
- By Cancer
- By Autoimmune Diseases
- By Inflammatory Diseases
- By Infectious Diseases
- By Others
- France Monoclonal Antibodies Market, By End User
- By Hospitals
- By Research Institutes
- By Others
- France Monoclonal Antibodies Market, By Source
- Spain
- Spain Monoclonal Antibodies Market, By Source
- By Murine
- By Chimeric
- By Humanized
- By Human
- Spain Monoclonal Antibodies Market, By Indication
- By Cancer
- By Autoimmune Diseases
- By Inflammatory Diseases
- By Infectious Diseases
- By Others
- Spain Monoclonal Antibodies Market, By End User
- By Hospitals
- By Research Institutes
- By Others
- Spain Monoclonal Antibodies Market, By Source
- Italy
- Italy Monoclonal Antibodies Market, By Source
- By Murine
- By Chimeric
- By Humanized
- By Human
- Italy Monoclonal Antibodies Market, By Indication
- By Cancer
- By Autoimmune Diseases
- By Inflammatory Diseases
- By Infectious Diseases
- By Others
- Italy Monoclonal Antibodies Market, By End User
- By Hospitals
- By Research Institutes
- By Others
- Italy Monoclonal Antibodies Market, By Source
- BENELUX
- BENELUX Monoclonal Antibodies Market, By Source
- By Murine
- By Chimeric
- By Humanized
- By Human
- BENELUX Monoclonal Antibodies Market, By Indication
- By Cancer
- By Autoimmune Diseases
- By Inflammatory Diseases
- By Infectious Diseases
- By Others
- BENELUX Monoclonal Antibodies Market, By End User
- By Hospitals
- By Research Institutes
- By Others
- BENELUX Monoclonal Antibodies Market, By Source
- Rest of Europe
- Rest Of Europe Monoclonal Antibodies Market, By Source
- By Murine
- By Chimeric
- By Humanized
- By Human
- Rest Of Europe Monoclonal Antibodies Market, By Indication
- By Cancer
- By Autoimmune Diseases
- By Inflammatory Diseases
- By Infectious Diseases
- By Others
- Rest Of Europe Monoclonal Antibodies Market, By End User
- By Hospitals
- By Research Institutes
- By Others
- Rest Of Europe Monoclonal Antibodies Market, By Source
- Germany
-
Asia Pacific Monoclonal Antibodies Market - Segment Analysis
- Overview
- Asia Pacific Monoclonal Antibodies Market, 2016 - 2028 (USD Million)
-
Asia Pacific Monoclonal Antibodies Market, by Source
- By Murine
- By Chimeric
- By Humanized
- By Human
-
Asia Pacific Monoclonal Antibodies Market, by Indication
- By Cancer
- By Autoimmune Diseases
- By Inflammatory Diseases
- By Infectious Diseases
- By Others
-
Asia Pacific Monoclonal Antibodies Market, by End User
- By Hospitals
- By Research Institutes
- By Others
-
Asia Pacific Monoclonal Antibodies Market, by Country
- China
- China Monoclonal Antibodies Market, By Source
- By Murine
- By Chimeric
- By Humanized
- By Human
- China Monoclonal Antibodies Market, By Indication
- By Cancer
- By Autoimmune Diseases
- By Inflammatory Diseases
- By Infectious Diseases
- By Others
- China Monoclonal Antibodies Market, By End User
- By Hospitals
- By Research Institutes
- By Others
- China Monoclonal Antibodies Market, By Source
- Japan
- Japan Monoclonal Antibodies Market, By Source
- By Murine
- By Chimeric
- By Humanized
- By Human
- Japan Monoclonal Antibodies Market, By Indication
- By Cancer
- By Autoimmune Diseases
- By Inflammatory Diseases
- By Infectious Diseases
- By Others
- Japan Monoclonal Antibodies Market, By End User
- By Hospitals
- By Research Institutes
- By Others
- Japan Monoclonal Antibodies Market, By Source
- India
- India Monoclonal Antibodies Market, By Source
- By Murine
- By Chimeric
- By Humanized
- By Human
- India Monoclonal Antibodies Market, By Indication
- By Cancer
- By Autoimmune Diseases
- By Inflammatory Diseases
- By Infectious Diseases
- By Others
- India Monoclonal Antibodies Market, By End User
- By Hospitals
- By Research Institutes
- By Others
- India Monoclonal Antibodies Market, By Source
- South Korea
- South Korea Monoclonal Antibodies Market, By Source
- By Murine
- By Chimeric
- By Humanized
- By Human
- South Korea Monoclonal Antibodies Market, By Indication
- By Cancer
- By Autoimmune Diseases
- By Inflammatory Diseases
- By Infectious Diseases
- By Others
- South Korea Monoclonal Antibodies Market, By End User
- By Hospitals
- By Research Institutes
- By Others
- South Korea Monoclonal Antibodies Market, By Source
- South East Asia
- South East Asia Monoclonal Antibodies Market, By Source
- By Murine
- By Chimeric
- By Humanized
- By Human
- South East Asia Monoclonal Antibodies Market, By Indication
- By Cancer
- By Autoimmune Diseases
- By Inflammatory Diseases
- By Infectious Diseases
- By Others
- South East Asia Monoclonal Antibodies Market, By End User
- By Hospitals
- By Research Institutes
- By Others
- South East Asia Monoclonal Antibodies Market, By Source
- Rest of Asia Pacific
- Rest of Asia Pacific Monoclonal Antibodies Market, By Source
- By Murine
- By Chimeric
- By Humanized
- By Human
- Rest of Asia Pacific Monoclonal Antibodies Market, By Indication
- By Cancer
- By Autoimmune Diseases
- By Inflammatory Diseases
- By Infectious Diseases
- By Others
- Rest of Asia Pacific Monoclonal Antibodies Market, By End User
- By Hospitals
- By Research Institutes
- By Others
- Rest of Asia Pacific Monoclonal Antibodies Market, By Source
- China
-
Latin America Monoclonal Antibodies Market - Segment Analysis
- Overview
- Latin America Monoclonal Antibodies Market, 2016 - 2028 (USD Million)
-
Latin America Monoclonal Antibodies Market, by Source
- By Murine
- By Chimeric
- By Humanized
- By Human
-
Latin America Monoclonal Antibodies Market, by Indication
- By Cancer
- By Autoimmune Diseases
- By Inflammatory Diseases
- By Infectious Diseases
- By Others
-
Latin America Monoclonal Antibodies Market, by End User
- By Hospitals
- By Research Institutes
- By Others
-
Latin America Monoclonal Antibodies Market, by Country
- Brazil
- Brazil Monoclonal Antibodies Market, By Source
- By Murine
- By Chimeric
- By Humanized
- By Human
- Brazil Monoclonal Antibodies Market, By Indication
- By Cancer
- By Autoimmune Diseases
- By Inflammatory Diseases
- By Infectious Diseases
- By Others
- Brazil Monoclonal Antibodies Market, By End User
- By Hospitals
- By Research Institutes
- By Others
- Brazil Monoclonal Antibodies Market, By Source
- Argentina
- Argentina Monoclonal Antibodies Market, By Source
- By Murine
- By Chimeric
- By Humanized
- By Human
- Argentina Monoclonal Antibodies Market, By Indication
- By Cancer
- By Autoimmune Diseases
- By Inflammatory Diseases
- By Infectious Diseases
- By Others
- Argentina Monoclonal Antibodies Market, By End User
- By Hospitals
- By Research Institutes
- By Others
- Argentina Monoclonal Antibodies Market, By Source
- Rest of Latin America
- Rest of Latin America Monoclonal Antibodies Market, By Source
- By Murine
- By Chimeric
- By Humanized
- By Human
- Rest of Latin America Monoclonal Antibodies Market, By Indication
- By Cancer
- By Autoimmune Diseases
- By Inflammatory Diseases
- By Infectious Diseases
- By Others
- Rest of Latin America Monoclonal Antibodies Market, By End User
- By Hospitals
- By Research Institutes
- By Others
- Rest of Latin America Monoclonal Antibodies Market, By Source
- Brazil
-
Middle East & Africa Monoclonal Antibodies Market - Segment Analysis
- Overview
- Middle East & Africa Monoclonal Antibodies Market, 2016 - 2028 (USD Million)
-
Middle East & Africa Monoclonal Antibodies Market, by Source
- By Murine
- By Chimeric
- By Humanized
- By Human
-
Middle East & Africa Monoclonal Antibodies Market, by Indication
- By Cancer
- By Autoimmune Diseases
- By Inflammatory Diseases
- By Infectious Diseases
- By Others
-
Middle East & Africa Monoclonal Antibodies Market, by End User
- By Hospitals
- By Research Institutes
- By Others
-
Middle East & Africa Monoclonal Antibodies Market, by Country
- GCC Countries
- GCC Countries Monoclonal Antibodies Market, By Source
- By Murine
- By Chimeric
- By Humanized
- By Human
- GCC Countries Monoclonal Antibodies Market, By Indication
- By Cancer
- By Autoimmune Diseases
- By Inflammatory Diseases
- By Infectious Diseases
- By Others
- GCC Countries Monoclonal Antibodies Market, By End User
- By Hospitals
- By Research Institutes
- By Others
- GCC Countries Monoclonal Antibodies Market, By Source
- South Africa
- South Africa Monoclonal Antibodies Market, By Source
- By Murine
- By Chimeric
- By Humanized
- By Human
- South Africa Monoclonal Antibodies Market, By Indication
- By Cancer
- By Autoimmune Diseases
- By Inflammatory Diseases
- By Infectious Diseases
- By Others
- South Africa Monoclonal Antibodies Market, By End User
- By Hospitals
- By Research Institutes
- By Others
- South Africa Monoclonal Antibodies Market, By Source
- Rest of Middle East & Africa
- Rest of Middle East & Africa Monoclonal Antibodies Market, By Source
- By Murine
- By Chimeric
- By Humanized
- By Human
- Rest of Middle East & Africa Monoclonal Antibodies Market, By Indication
- By Cancer
- By Autoimmune Diseases
- By Inflammatory Diseases
- By Infectious Diseases
- By Others
- Rest of Middle East & Africa Monoclonal Antibodies Market, By End User
- By Hospitals
- By Research Institutes
- By Others
- Rest of Middle East & Africa Monoclonal Antibodies Market, By Source
- GCC Countries
-
Key Market Dynamics
- Introduction
- Market Drivers
- Market Restraints
- Market Opportunities
- Porter's Five Forces Analysis
- PEST Analysis
- Regulatory Landscape
- Technology Landscape
- Regional Market Trends
-
COVID 19 Impact Analysis
- Key strategies undertaken by companies to tackle COVID-19
- Short term dynamics
- Long term dynamics
-
Marketing Stratagy Analysis
- Marketing Channel
- Direct Marketing
- Indirect Marketing
- Marketing Channel Development Trends
-
Competative Landscape
- Competition Matrix - 2021
- Company Market Share Analysis - 2021
- Key Company Activities, 2018 - 2021
- Strategic Developments - Heat Map Analysis
- Company Offering Evaluation
- Company Regional Presence Evaluation
-
Company Profiles
- Abbott Laboratories
- Amgen Inc.
- AstraZeneca PLC
- Bayer AG
- Eli Lilly
- GlaxoSmithKline PLC
- Johnson & Johnson
- Merck & Co. Inc.
- Novartis
- Pfizer
- Key Primary Respondents - VERBATIM
- Discussion Guide
- Customization Offered
- Annexure
- List of Figures
- List of Tables
- List of Abbreviations
FAQ
Frequently Asked Question
What is the global demand for Monoclonal Antibodies in terms of revenue?
-
The global Monoclonal Antibodies valued at USD 111.93 Billion in 2022 and is expected to reach USD 186.67 Billion in 2030 growing at a CAGR of 6.60%.
Which are the prominent players in the market?
-
The prominent players in the market are Abbott Laboratories, Amgen Inc., AstraZeneca PLC, Bayer AG, Eli Lilly, GlaxoSmithKline PLC, Johnson & Johnson, Merck & Co. Inc., Novartis, Pfizer.
At what CAGR is the market projected to grow within the forecast period?
-
The market is project to grow at a CAGR of 6.60% between 2023 and 2030.
What are the driving factors fueling the growth of the market.
-
The driving factors of the Monoclonal Antibodies include
- Rise in prevalence of various cancer types
Which region accounted for the largest share in the market?
-
North America was the leading regional segment of the Monoclonal Antibodies in 2022.